Template:Formulations and brand names of norethisterone and esters
Appearance
Composition | Dose | Brand names | Use |
---|---|---|---|
NET only | Low (e.g., 0.35 mg) | Multiple[a] | Progestogen-only oral contraceptive |
NET or NETA only | High (e.g., 5 mg, 10 mg) | Multiple[b] | Gynecological disorders and other uses |
NETE only | Injection (e.g., 200 mg) | Multiple[c] | Progestogen-only injectable contraceptive |
NET or NETA with ethinylestradiol | Low (e.g., 0.4 mg, 0.5 mg, 0.75 mg, 1 mg, 1.5 mg) | Multiple[d] | Combined oral contraceptive |
NET with mestranol | Low (e.g., 1 mg, 2 mg) | Multiple[e] | Combined oral contraceptive |
NETA with estradiol | Low (e.g., 0.1 mg, 0.5 mg) | Multiple[f] | Combined menopausal hormone therapy |
NETE with estradiol valerate | Injection (e.g., 50 mg) | Multiple[g] | Combined injectable contraceptive |
Abbreviations: NET = Norethisterone. NETA = Norethisterone acetate. NETE = Norethisterone enanthate. Sources: [1][2] [3][4] Notes:
|
References
[edit]- ^ "Norethisterone". Drugs.com.
- ^ "Drugs@FDA: FDA Approved Drug Products". United States Food and Drug Administration. Archived from the original on 16 November 2016. Retrieved 27 November 2016.
- ^ Index Nominum 2000: International Drug Directory. Taylor & Francis. January 2000. pp. 749–. ISBN 978-3-88763-075-1.
- ^ IARC Working Group on the Evaluation of Carcinogenic Risks to Humans; International Agency for Research on Cancer (1 January 1999). Hormonal Contraception and Post-menopausal Hormonal Therapy (PDF). IARC. p. 65. ISBN 978-92-832-1272-0.